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A B S T R A C T
Upon oral administration the solubility of a drug in intestinal ﬂuid is a key property inﬂuencing bioavailability.
It is also recognised that simple aqueous solubility does not reﬂect intestinal solubility and to optimise in vitro
investigations simulated intestinal media systems have been developed. Simulated intestinal media which can
mimic either the fasted or fed state consists of multiple components each of which either singly or in combi-
nation may inﬂuence drug solubility, a property that can be investigated by a statistical design of experiment
technique. In this study a design of experiment covering the full range from the lower limit of fasted to the upper
limit of fed parameters and using a small number of experiments has been performed. The measured equilibrium
solubility values are comparable with literature values for simulated fasted and fed intestinal ﬂuids as well as
human fasted and fed intestinal ﬂuids. The equilibrium solubility data range is statistically equivalent to a
combination of published fasted and fed design of experiment data in six (indomethacin, phenytoin, zaﬁrlukast,
carvedilol, fenoﬁbrate and probucol) drugs with three (aprepitant, tadalaﬁl and felodipine) drugs not equivalent.
In addition the measured equilibrium solubility data sets were not normally distributed. Further studies will be
required to determine the reasons for these results however it implies that a single solubility measurement
without knowledge of the solubility distribution will be of limited value. The statistically signiﬁcant media
factors which promote equilibrium solubility (pH, sodium oleate and bile salt) were in agreement with published
results but the number of determined signiﬁcant factors and factor interactions was fewer in this study, lecithin
for example did not inﬂuence solubility. This may be due to the reduction in statistical sensitivity from the lower
number of experimental data points or the fact that using the full range will examine media parameters ratios
that are not biorelevant. Overall the approach will provide an estimate of the solubility range and the most
important media factors but will not be equivalent to larger scale focussed studies. Further investigations will be
required to determine why some drugs do not produce equivalent DoE solubility distributions, for example
combined fasted and fed DoE, but this simply may be due to the complexity and individuality of the interactions
between a drug and the media components.
1. Introduction
Dissolution and solubility are essential parameters in the absorption
process of orally administered drugs and especially for poorly soluble
drugs (BCS class II and IV). Over the last two decades there has been an
increasing development of molecules with low aqueous solubility due
to the application during development of high throughput screening
systems (Lipinski et al., 2001). Therefore, it is necessary to develop new
formulation techniques in order to address this issue (Savjani et al.,
2012) along with in vitro methods to predict drug solubility in gas-
trointestinal ﬂuids (Lennernas et al., 2014). High throughput solubility
screening is possible (Alsenz and Kansy, 2007) but a low aqueous so-
lubility does not automatically mean poor gastrointestinal solubility.
The solubilizing potential of the gastrointestinal environment can im-
prove the bioavailability for some drugs over that predicted on the basis
of simple aqueous solubility (Sunesen et al., 2005). For example, it has
been reported that mixtures of bile salts increase the solubility of
steroid formulations (Mithani et al., 1996; Wiedmann et al., 2002) and
the interaction of lecithin with bile salts yields an even greater positive
solubility eﬀect (Naylor et al., 1993). Solubilisation can be further in-
ﬂuenced by the formation of mixed micelles with other lipid digestion
products such as monoglycerides and the interaction of monoglycerides
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with bile salt was demonstrated to increase the solubility of alpha-to-
copherol in comparison to bile salt alone (Nielsen et al., 2001). To
address the problem of poor aqueous solubility and bioavailability for
oral drug formulations, it is therefore essential to use solubility and
dissolution test conditions which closely reproduce key parameters of
human gastrointestinal physiology (Dressman et al., 2007).
Over the past two decades simulated gastrointestinal media for the
human fasted and fed states have been developed to assist in vitro drug
development and formulation studies (Markopoulos et al., 2015;
Stappaerts et al., 2014). These media were based around available lit-
erature data on the detailed composition and physicochemical para-
meters of human GI ﬂuid however, the gastrointestinal tract and the
interactions of all its constituents is very complex. To assess these in-
teractions and improve the determination of the pivotal factors inﬂu-
encing the intestinal solubility of BCS class II drugs, a statistical design
of experiment (DoE) approach was applied to investigate the inﬂuence
of simulated gastrointestinal media composition in the fasted (Khadra
et al., 2015) and fed state (Zhou et al., 2017) on the equilibrium so-
lubility of BCS II compounds. This illustrated the utility of this ap-
proach, provided solubility values that are in agreement with literature
values and highlighted the diﬀerences in solubility between the fasted
and fed state (Augustijns et al., 2014; Bevernage et al., 2010; Clarysse
et al., 2011). In addition, the approach simulated the inherent solubility
variability and determined the key parameters controlling a drug's so-
lubility. For acidic compounds pH was the most signiﬁcant factor. For
basic and neutral drugs the combination of pH and concentration of
sodium oleate, bile salt and lecithin was signiﬁcant. Various interac-
tions between media components and unusual drug speciﬁc solubility
behaviour were also identiﬁed. For neutral drugs solubilisation in fed
simulated media was a more complicated interplay since seven (pH,
oleate, bile salt, lecithin, monoglyceride, buﬀer and pancreatin) out of
the eight single factors were signiﬁcant along with more than half of the
factor interactions.
In this paper the design of experiment approach has been applied to
explore the equilibrium solubility of BCS class II drugs in simulated
media spanning the full range of both fasted and fed intestinal states in
a single experiment. The purpose is to examine the feasibility of mer-
ging the individual fasted and fed studies into one reduced experiment
in order to obtain comparable results from a smaller experimental load.
In this full range DoE the simulated intestinal ﬂuid consists of seven
factors or parameters (sodium oleate, bile salt, pH, lecithin, buﬀer, salt
and monoglyceride) with phosphate buﬀer used instead of maleic acid.
A fractional factorial design with two levels (upper and lower limit) was
applied requiring a total of thirty two measurements and conducted in
duplicate. This gives a total of 64 measurements for the statistical
analysis. The lower limit values are derived from the lower limits of the
literature fasted study (Khadra et al., 2015) and the upper limits are
from the upper limits of fed study (Zhou et al., 2017) (Table 1). A
smaller scaled DoE was selected in order to assess the utility of this
systematic approach with a limited number of measurements. The
equilibrium solubility of nine BCS class II drugs was investigated, two
acids (indomethacin and phenytoin), four bases (aprepitant,1 tadalaﬁl,
zaﬁrlukast and carvedilol) and three neutral drugs (felodipine, fenoﬁ-
brate, probucol) and compared to the previous fasted and fed DoE
studies.
2. Materials and methods
2.1. Materials
Sodium taurocholate, ammonium formate, sodium chloride (NaCl),
chloroform, formic acid, monosodium phosphate (NaH2PO4), fenoﬁ-
brate, indomethacin and phenythoin were purchased from Sigma
Aldrich Poole, Dorset UK. Lecithin S PC (phosphatidylcholine from
Soybean “98%”) was purchased from Lipoid. Glycerol mono oleate was
obtained from CRODA Healthcare. The active pharmaceutical in-
gredients felodipine, probucol, aprepitant, tadalaﬁl, carvedilol and za-
ﬁrlukast were provided through OrBiTo by Dr. R. Holm Head of
Preformulation, Lundbeck, Denmark. Sodium oleate was obtained from
BDH Chemical Ltd. Poole England. The analytical solvents methanol
and acetonitrile were of HPLC grade (VWR, UK). All water was ultra
pure Milli-Q water.
2.2. Design of experiment and data analysis
A quarter of the full factorial design of experiment with 7 factors
(either a component concentration or a system parameter such as pH)
and 2 levels (upper and lower limits) was constructed and analysed
using Minitab®17.2.1. Minitab generated 32 diﬀerent experiments by
various combinations of the upper and lower limits of the 7 factors
based on Table 1 (no centre point and no replicate). When designing
and analysing the DoE assumptions were made. 1. Only main eﬀects
and 2-way interactions are considered in the analysis and 3-way in-
teractions or more were not considered. 2. The single factors and factor
interactions are confounded with 3 to 6-way interactions which were
not included. There are three confounded 2-way factor interactions,
sodium oleate and salt with buﬀer and monoglyceride, sodium oleate
and buﬀer with salt and monoglyceride, sodium oleate and mono-
glyceride with salt and buﬀer. For these interactions if the result is
signiﬁcant then any conclusions must be drawn with caution as it might
be the result of the four factors together or only one of the 2 way in-
teractions. 3. The main eﬀect can be positive (+) or negative (−), but
when it is involved in an interaction, the conclusion will be considered
with the interactions (± ).
The Kolmogorov normality test was used in Minitab® to assess the
distribution of each data set, based on the result that all data sets have a
non-normal distribution the Mann-Whitney test was applied to evaluate
diﬀerences between two data sets.
2.3. Equilibrium solubility measurements
2.3.1. Preparation of lipid stock mixtures
Sodium taurocholate, monoglyceride and lecithin were weighed
into a ﬂask and 2 ml of chloroform was added to dissolve all the solid
material. A stream of nitrogen gas was used to remove the chloroform
ensuring a dry ﬁlm was produced. Water was added to reform the dried
ﬁlm, stirred to obtain a homogenous mixture, transferred to a
Table 1
Composition and concentration levels employed in full range design of experiment.
Parameter Substance Lower limit
fasted
Upper
limit fed
Bile salt (mM) Sodium taurocholate 1.5 24
Lecithin (mM) Phosphatidylcholine 0.2 4.8
Fatty acid (mM) Sodium oleate 0.5 52
pH Sodium hydroxide/
hydrochloric acid
5 7
Salt (mM) Sodium chloride 68 203
Buﬀer (mM) Phosphatea 15 45
Monoglyceride (mM) Glyceryl mono-oleate 0.5 6.5
a Monophosphate buﬀer (KH2PO4).
1 Aprepitant has been classiﬁed as a basic drug in order to assist comparison with the
two previous Design of Experiment studies (Khadra et al., 2015; Zhou et al., 2017), it is
recognised that with a reported pKa of 9.7 (Liu et al., 2015) at the pH values in this study
it will be predominantly un-ionised.
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volumetric ﬂask (5 ml) and made to volume with water.
2.3.2. Preparation of aqueous stock solutions
Salt and buﬀer stock solution: Sodium chloride (4.448 g) and
monosodium phosphate (NaH2PO4) (2.395 g) were weighed into a
25 ml volumetric ﬂask, dissolved and made up to the volume with
water.
Sodium oleate: Sodium oleate (1.978 g) was weighed into a 25 ml
volumetric ﬂask, dissolved in water under gentle heat and made to ﬁnal
volume. Solution was then kept at 50 °C to aid solubilisation.
2.3.3. Preparation of measurements solutions
The concentration of each stock mixture has been designed to be 15
times greater than the upper limit concentration value required for the
DoE, with the exception of sodium oleate where only a 5 times con-
centration was possible. The stock mixtures were combined to provide
the 32 measurement solutions according to the DoE model.
2.3.4. Determination of equilibrium solubility
This protocol has been previously validated to ensure equilibrium
solubility is achieved after 24 h with no methodological interference
(Khadra et al., 2015; Zhou et al., 2017). A weight of powdered drug
(10 mg) was added to a centrifuge tube (15 ml Corning®). The required
volume of each stock solution (section above) and water was added to
provide a ﬁnal volume of 4 ml in every tube. pH was then adjusted to 5
or 7 using 0.1 M HCL or 0.1 M KOH. Tubes were shaken for 1 h at room
temperature and then pH adjusted again as before. Tubes are then
placed in an orbital shaker and incubated for 24 h at 37 °C and
240 rpm. Following incubation the tubes were checked for the presence
of solid drug, then centrifuged (13,000 rpm, 5 min) and the supernatant
(500 μl) was sampled to determine the solubilised drug concentration
by HPLC. Assays conditions are presented in Table 2.
3. Results and discussion
3.1. Equilibrium solubility measurements
The results of the full range DoE equilibrium solubility measure-
ment are presented in Fig. 1 and a broad range of solubility values are
observed with heterogeneous variability from one to three orders of
magnitude depending on the drug. As a comparison literature solubility
values were available for six drugs in fasted or fed state simulated in-
testinal ﬂuid (SIF) and/or human intestinal ﬂuid (HIF) (Augustijns
et al., 2014) and are plotted in Fig. 1. Those results are comparable in
each case and lie within the DoE range of the solubility values reported
in this study. It is evident that drug speciﬁc factors are aﬀecting solu-
bility with some compounds felodipine and tadalaﬁl showing a large
variability while phenytoin and aprepitant show more consistency.
In Fig. 2a–c the published fasted (Khadra et al., 2015) and fed (Zhou
et al., 2017) DoE measurements are plotted for each drug along with
the full range data and displayed by group. For acidic drugs (Fig. 2a)
the concentration points are comparable with the previous fasted and
fed studies with the solubility of phenytoin very consistent while in-
domethacin exhibits a larger variability. The respective pKa of the
drugs 8.1 and 4.5 could explain this diﬀerence since phenytoin is un-
ionised over the experimental pH range whilst indomethacin is pre-
dominantly ionised. In addition Indomethacin is more lipophilic (log
P= 4.3) which will increase its interaction with the micellar phase. For
the basic drugs (Fig. 2b) tadalaﬁl and carvedilol the previous fasted and
fed data are comparable to the full range experiment whilst zaﬁrlukast
and aprepitant do not show the same consistency. The full range DoE
was not able to determine the lowest concentrations for both drugs.
Zaﬁrlukast has the biggest diﬀerence between the lowest fasted and
highest fed values (4 orders of magnitude). In addition the distribution
of the full range data points is the most homogenous compared to the
other distributions. This compound has the highest log P value (5.4)
and a pKa of 4.3 which means that the non-ionised form is predominant
over the pH range. Carvedilol and tadalaﬁl are largely ionised between
pH 5 and 7 according to their respective pKa values of 7.8 and 10 while
Table 2
HPLC assays conditions.
Columna Drug Mobile phase Flow rate (ml/
min)
Injection volume
(μl)
Detection (nm) Retention time
(min)
R2b LOQ (μM)
2 Indomethacin Mobile phase A: Ammonium formate 10 mM
pH 3.0 in H2O
Mobile phase B: Ammonium formate 10 mM
pH 3.0 in ACN/H2O
(9:1 v/v)
1 10 254 0.84 0.9919 0.31
2 Phenytoin 1 10 260 2.3 0.9961 51
1 Felodipine 1 10–50 260 3.1 0.9997 9.4
1 Fenoﬁbrate 1 10 291 3.7 0.994 0.94
1 Probucol 1 10–50 254 4.5 0.9999 2.5
1 Aprepitant 1 10 254 3.0 0.9995 26
2 Tadalﬁl 1 10 291 2.1 0.998 1.9
2 Zaﬁrlukast 1 10 260 2.9 0.9991 0.27
2 Carvedilol 1 10 254 1.0 0.9999 9.0
Apparatus Agilent Technologies 1260 Series Liquid Chromatography system with Clarity Chromatography software: Gradient method: Time 0, 70%A:30%B, 3 min 0%A:100%B, 4 min
0%A:100%B, 4.5 min 70%A:30%B total run time 8 min. ACN: acetonitrile. LOQ: Limit of Quantiﬁcation.
a Column 1 Hichrom ACE 3 C18/DV148262/50 × 3.0 mm id/ACE-111-0503/A149937: Column 2 Hichrom ACE 3 C18/SIN-A46224/50 × 2.1 mm/ACE-111-0502/A46224.
b R2 Linear regression coeﬃcient of calibration curve, n= 5 or 6 points.
Fig. 1. Design of experiment equilibrium solubility measurements.
Legend: Equilibrium solubility measurements for each drug in DoE media compositions
detailed in Table 1. Red coloured data points for acidic drugs, yellow for neutral drugs
and blue basic drugs. ∆ and + reported solubility values for individual drugs in fasted
simulated intestinal ﬂuid and fed simulated intestinal ﬂuid media respectively, ○ and▽
reported solubility values for individual drugs in fasted human intestinal ﬂuid and fed
human intestinal ﬂuid respectively, all values from (Augustijns et al., 2014). (For inter-
pretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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the ampholyte Aprepitant is considered as a neutral compound between
pH 5 and 7. The lipohilicity of aprepitant (log P= 4.5) and carvedilol
(log P= 4.2) could explain the slightly higher solubility observed. For
neutrals (Fig. 2c) depending on the drug the full range experiment was
able to determine very low concentrations. Neutral compounds are not
ionisable therefore lipophilicity plays an important role in the solubi-
lisation by surfactants and micelles. Felodipine and fenoﬁbrate (log
P= 3.8 and 5.2 respectively) behave similarly since the full range
covered the fasted and fed space and the lowest concentration corre-
sponds to the lowest point of the fasted experiment. However, the so-
lubility of probucol is lower which may indicate that its very high li-
pophilicity (log P= 10.9) might limit solubilisation. Interestingly the
measured equilibrium solubility values indicate that the full range DoE
covered the solubility space of the previous fasted and fed DoE for the
majority of the drugs. This outcome means the full range DoE is cov-
ering an appropriate solubility space and that a reduced experimental
size DoE could be suﬃcient to explore the intestinal solubility varia-
bility in simulated media.
3.2. Statistical comparisons
All the data sets resulted in a non-normal distribution, which based
on the number of data points (fasted DoE = 66 (Khadra et al., 2015),
fed DoE = 92 (Zhou et al., 2017), full range = 32) was not expected
and may arise either through the non-normal sample pattern induced
by the DoE structure and or the fact that drug solubility is not normally
distributed in the sample space. The latter explanation is supported by
human intestinal ﬂuid characterization studies which indicate that bile
salt and lecithin in the fasted state have skewed concentration dis-
tributions (Riethorst et al., 2015) and HIF solubility studies measuring
diﬀerences between mean and median solubility values (Psachoulias
et al., 2011) indicating a non-normal solubility distribution. Further
studies will be required to fully explore this interesting statistical
property. A non-parametric Mann-Whitney test was therefore applied to
compare distributions and the p-values are displayed in Fig. 2a–c.
It is evident for all the drugs that the solubility values are statisti-
cally signiﬁcantly lower in the fasted than the fed state which is in
agreement with the literature data (Augustijns et al., 2014; Bevernage
et al., 2010; Clarysse et al., 2011) and indicates that the published DoE
(Khadra et al., 2015; Zhou et al., 2017) studies have explored diﬀerent
solubility spaces. A comparison of the published fasted or fed solubility
distributions with the current full range DoE indicates that there is a
statistically signiﬁcant diﬀerence for fourteen (approximately 80%) out
of the possible eighteen (two for each of the nine drugs tested) com-
parisons. In the fasted state phenytoin and carvedilol and in the fed
state zaﬁrlukast and felodipine are statistically equivalent to the com-
bined DoE. The diﬀerence between fasted or fed compared to combined
is to be expected based on the previous comparison between fasted and
fed, which determined that these are separate solubility distributions.
In the case of phenytoin and carvedilol in the fasted and felodipine in
the fed DoE the similarity can be ascribed to the narrow solubility
a
b
c
Fig. 2. Statistical comparison of design of experiment equilibrium solubility measure-
ments.
a: Acidic drugs.
Legend: Equilibrium solubility measurements for each drug in full range design of
experiment media. Box and whisker plots from top to bottom the maximum value, 75th
percentile, median, 25th percentile and minimum value, fasted design of experiment
solubility data (Khadra et al., 2015); fed design of experiment solubility data (Zhou
et al., 2017). KS statistic value of Kolmogorov normality test on the data set, if p-value
is< 0.05 the distribution is non-normal. Mann-Whitney non parametric test determine
whether the population medians of two groups diﬀer, not signiﬁcant (NS) if p-value >
0.05; * if p-value≤ 0.05; ** if p-value≤ 0.01; *** if p-value≤ 0.001 and **** if p-
value≤ 0.0001.
b: Basic drugs.
Legend: Equilibrium solubility measurements for each drug in full range design of
experiment media. Box and whisker plots from top to bottom the maximum value, 75th
percentile, median, 25th percentile and minimum value, fasted design of experiment
solubility data (Khadra et al., 2015); fed design of experiment solubility data (Zhou
et al., 2017). KS statistic value of Kolmogorov normality test on the data set, if p-value
is< 0.05 the distribution is non-normal. Mann-Whitney non parametric test determine
whether the population medians of two groups diﬀer, not signiﬁcant (NS) if p-value >
0.05; * if p-value≤ 0.05; ** if p-value≤ 0.01; *** if p-value≤ 0.001 and **** if p-
value≤ 0.0001.
c: Neutral drugs.
Legend: Equilibrium solubility measurements for each drug in full range design of
experiment media. Box and whisker plots from top to bottom the maximum value, 75th
percentile, median, 25th percentile and minimum value, fasted design of experiment
solubility data (Khadra et al., 2015); fed design of experiment solubility data (Zhou
et al., 2017). KS statistic value of Kolmogorov normality test on the data set, if p-value
is< 0.05 the distribution is non-normal. Mann-Whitney non parametric test determine
whether the population medians of two groups diﬀer, not signiﬁcant (NS) if p-value >
0.05; * if p-value≤ 0.05; ** if p-value≤ 0.01; *** if p-value≤ 0.001 and **** if p-
value≤ 0.0001.
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distribution, which ﬁts inside the full range distribution, whilst for
zaﬁrlukast there is a broad overlapping between fed and full range.
A comparison of the combined fasted and fed solubility data, which
if additive should represent the full solubility range, with the full range
DoE indicates that there is no signiﬁcant diﬀerence for six (phenytoin,
indomethacin, zaﬁrlukast, carvedilol, fenoﬁbrate, probucol) out of the
nine drugs tested but aprepitant, tadalaﬁl and felodipine are sig-
niﬁcantly diﬀerent. The statistical equivalence between a combination
of published fasted and fed data with the full range DoE data is to be
expected if both experiments are sampling the same solubility space.
The statistically signiﬁcant diﬀerence determined for aprepitant, tada-
laﬁl and felodipine appears to be related to the trend towards higher
“fed” like solubility values in the full range DoE, when compared to the
solubility for the combined fasted and fed data. However, for aprepitant
and tadalaﬁl there is a statistically signiﬁcant diﬀerence between all
data sets (Fig. 2b) indicating that these drugs are exhibiting complex
behaviour. This discrepancy in one third of the tested drugs might be
due to the aforementioned issue that the application of a DoE approach
samples the solubility space in a structured rather than random fashion
and therefore statistical comparison might not be valid. Conversely, two
thirds of the tested drugs behave in a manner that is consistent with
published paradigms.
The current solubility results match literature data (Fig. 1) where
available indicating that the DoE approaches are investigating a re-
levant solubility zone, but there are no equivalent large literature data
sets available for statistical comparison. Almost all published solubility
studies in either human intestinal ﬂuids (Augustijns et al., 2014;
Clarysse et al., 2009; Kleberg et al., 2010) or simulated intestinal ﬂuids
(Clarysse et al., 2011; Fuchs and Dressman, 2014; Ilardia-Arana et al.,
2006; Khadra et al., 2015; Zhou et al., 2017) indicate that there are
drug dependent variations in solubility over and above those induced
by variations in media composition. In combination with the results in
this study this indicates that a substantial proportion, around one third,
of drugs most probably basic or neutral compounds, will exhibit be-
haviour at the extremes of current literature based patterns.
3.3. Solubility inﬂuence of individual DoE factors
For each DoE experiment Minitab calculates an individual factor's
standardised eﬀect on the magnitude and direction of the measured
equilibrium solubility, allowing a comparison between factors and
drugs. For each drug, statistically signiﬁcant standardised eﬀect values
in the full range study are presented in Fig. 3 along with the standar-
dised eﬀect value for that factor in the published fasted and fed studies
(Khadra et al., 2015; Zhou et al., 2017). NB For each drug non-statis-
tically signiﬁcant factor eﬀects in this study are not presented in Fig. 3,
which does not mean that a statistically signiﬁcant eﬀect was not de-
termined in either the fasted or fed study.
The eﬀects of the full range media factors on the drugs are complex
because each drug displays a unique proﬁle a result that is similar to the
previous fasted (Khadra et al., 2015) and fed (Zhou et al., 2017) studies.
The media components showing the lowest eﬀect on the solubility are
buﬀer and monoglyceride (0 signiﬁcant results from 9 drugs) followed
by salt and lecithin (1 signiﬁcant from 9), whilst the factors with the
biggest inﬂuence are pH, bile salt (6 signiﬁcant results from 9) and
sodium oleate (7 from 9). This is comparable to the fasted and fed state
DoE where bile salt, pH and sodium oleate were the dominant sig-
niﬁcant factors but contrasting for lecithin which was also signiﬁcant in
these studies. However, the amplitude of the eﬀect diﬀers between
groups and individual drugs conﬁrming the complexity of the interplay
between each drug and the system, a feature higlighted in both previous
DoE studies. The means of the absolute standardised eﬀect values
grouped for acidic, basic and neutral drugs are presented in Fig. 4. This
provides information on the overall magnitude of a factors inﬂuence
but masks the direction of the eﬀect. For the three groups of drugs pH,
sodium oleate and bile salt have a statistically signiﬁcant inﬂuence on
solubility in the full range study which is in accordance with the pre-
vious reported experiments (Khadra et al., 2015; Zhou et al., 2017).
For acidic compounds (Fig. 3a–b) pH is the most signiﬁcant factor,
which is identical to the two previously reported DoE studies and has
already been described for acidic compounds (Clarysse et al., 2009).
The direction of eﬀect is comparable (positive) but the magnitude is
lower when compared to the published fasted study and similar to the
fed study. Sodium oleate and bile salt are the second most signiﬁcant
factors with a positive direction of eﬀect, which is in agreement with
the published fasted and the fed state. On the contrary buﬀer had no
inﬂuence even though it was signiﬁcant for the two compounds in the
fasted study with a positive eﬀect for phenytoin and a negative eﬀect
for indomethacin. The inﬂuence of the remaining factors (lecithin, salt
and monoglyceride) is also negative.
For basic compounds (Fig. 3c–f) sodium oleate, pH and bile salt are
the predominant factors but this eﬀect is variable between drugs.
Aprepitant, carvedilol and tadalaﬁl are positively aﬀected by sodium
oleate whilst bile salt only positively aﬀects tadalaﬁl and zaﬁrlukast.
The inﬂuence of pH is not as important as for acidic drugs with a sig-
niﬁcant eﬀect featured for aprepitant, carvedilol and zaﬁrlukast but not
tadalaﬁl. An enhanced solubility is coherent with an increase of pH
from 5 to 7 for the weak base zaﬁrlukast, pKa value of 4.3 inﬂuencing
drug ionisation but for aprepitant (pKa = 9.7) this solubility change
has to arise via another mechanism. Surprisingly lecithin was not sig-
niﬁcant which is at variance from the published DoE where sodium
oleate, bile salt, pH and lecithin were signiﬁcant for basic drugs.
For neutral compounds (Fig. 3g and h) only felodipine and fenoﬁ-
brate were signiﬁcantly aﬀected by any factors. Sodium oleate and bile
salt had a positive eﬀect on both drugs whilst pH and lecithin only
aﬀected felodipine in both cases in agreement with both studies in
fasted and fed states. On the other hand probucol was not signiﬁcantly
inﬂuenced by any of the factors although previously oleate, bile salt,
pH, lecithin salt and monoglyceride were detected as signiﬁcant. The
inﬂuence of pH cannot change drug ionisation therefore for these drugs
the solubility inﬂuence has to be associated with a change in ionisation
of the media components as presented previously (Khadra et al., 2015;
Pedersen et al., 2000a; Zhou et al., 2017). Finally buﬀer, salt and
monoglycerides showed a very small inﬂuence on solubility with very
low magnitude mostly below the signiﬁcant level, reﬂecting the fasted
study but contrasting with the fed study where almost all the compo-
nents were signiﬁcant.
3.4. Solubility inﬂuence of DoE factor interactions
The experiment consisted of seven factors and a possible twenty one
interactions between the factors. Only 2-way interactions were con-
sidered. Three confounded interactions are present, sodium oleate and
salt with buﬀer and monoglyceride, sodium oleate and buﬀer with salt
and monoglyceride, sodium oleate and monoglyceride with salt and
buﬀer. For each drug, statistically signiﬁcant standardised eﬀect values
for factor interactions in the full range study are presented in Fig. 5
along with the standardised eﬀect value for that factor interaction in
the published fasted and fed studies (Khadra et al., 2015; Zhou et al.,
2017). NB For each drug non-statistically signiﬁcant factor interactions
in this study are not presented in Fig. 5, which does not mean that a
statistically signiﬁcant eﬀect was not determined in either the fasted or
fed study. Among all the possible factor combinations in this full range
DoE a statistically signiﬁcant eﬀect was present eighteen times which
represents approximately 10% of the possibilities. For neutral and
acidic drugs eight and seven signiﬁcant interactions featured respec-
tively while for basic drugs only three. This contrasts with the fasted
and fed DoE where respectively one third and one ﬁfth of the interac-
tions were signiﬁcant.
For acidic drugs (Fig. 5a–b) the eﬀect of factor interactions is con-
sistent within the group, bile salt or sodium oleate are associated in
each signiﬁcant interaction and pH is only present in three of them. The
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limited eﬀect of pH is surprising since the pKa values of the two acidic
factors (oleate and bile salt) is approximately 5 (Holm et al., 2013) and
the DoE range is 5–7 which must induce variation in factor ionisation.
Interestingly the combination of salt and monoglyceride is signiﬁcant
for both compounds, which could be a confounded eﬀect since this
interaction is linked with sodium oleate and buﬀer. For basic com-
pounds (Fig. 5c–e) only three signiﬁcant interactions were highlighted
and they all include pH with either bile salt or sodium oleate. This is
expected as these factors were predominant in the single factor analysis
and also reported during the fasted and fed DoE. For neutrals drugs
Fig. 3. Statistically signiﬁcant standardised eﬀect values for
individual DoE factors on equilibrium solubility.
Legend: DoE standardised eﬀect values for individual factors (as
listed in ﬁgure y-axis) on equilibrium solubility. Vertical black
lines indicate statistical signiﬁcance (p < 0.05), horizontal bar
direction indicates direction of eﬀect, to the right of 0 on axis is
positive eﬀect on solubility, bar length indicates the magnitude
of the eﬀect. Full: value from current study, Fa: fasted data from
(Khadra et al., 2015), Fe: fed data from (Zhou et al., 2017). NB
For each drug non-statistically signiﬁcant factor eﬀects in this
study are not presented.
Fig. 4. Average absolute standardised eﬀect values for in-
dividual DoE factors on equilibrium solubility.
Legend: Average absolute (NB this removes direction of
eﬀect information) standardised eﬀect values for in-
dividual factors on equilibrium solubility grouped by drug
category. Horizontal black line indicates statistical sig-
niﬁcance (p < 0.05). Acidic Drugs; current full range
study, fasted design of experiment solubility data
(Khadra et al., 2015); fed design of experiment solubility
data (Zhou et al., 2017). Basic Drugs; current full range
study, fasted design of experiment solubility data
(Khadra et al., 2015); fed design of experiment solubility
data (Zhou et al., 2017). Neutral Drugs; current full range study, fasted design of experiment solubility data (Khadra et al., 2015); fed design of experiment solubility data (Zhou
et al., 2017).
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(Fig. 5f–h) all the signiﬁcant interactions are associated with bile salt or
sodium oleate. Although the oleate and salt interaction for fenoﬁbrate is
confounded with buﬀer and monoglyceride. The positive eﬀect of sur-
factant has been previously reported in the fasted and fed DoE for this
group of drugs.
3.5. Statistically signiﬁcant solubility factor and factor interactions
The mean of the absolute eﬀect value of all statistically signiﬁcant
factor and factor interactions arranged by drug group is presented in
Fig. 6 in order to summarise the full range experimental results. When
comparing factor interactions between this full range and published
results conclusions should be made with prudence since the fed study
employed a diﬀerent statistical design of experiment (Zhou et al.,
2017). For the acidic drugs pH is not surprisingly the principal factor. In
the published fasted (Khadra et al., 2015) and fed (Zhou et al., 2017)
study pH is involved in every statistically signiﬁcant combination with
either sodium oleate, bile salt or buﬀer. These interactions are con-
ﬁrmed in the full range experiment as pH, sodium oleate and bile salt
are responsible for three out of four. The signiﬁcant interaction of salt
with monolgyceride is a result that is not present in the published fed
DoE (Zhou et al., 2017) but is a confounded interaction in this study
with sodium oleate with buﬀer, it is therefore likely that this is due to a
dominant eﬀect arising from sodium oleate. For the basic drugs sodium
oleate, pH, bile salt and the interaction between sodium oleate and pH
was found to be statistically signiﬁcant. Interestingly those components
are involved in the two signiﬁcant interactions highlighted in the fed
DoE (pH ∗ sodium oleate and lecithin ∗ sodium oleate) (Zhou et al.,
2017). However, in the fasted DoE six diﬀerent interactions were sig-
niﬁcant, pH with sodium oleate, salt and lecithin, bile salt with sodium
oleate and buﬀer and then lecithin with salt. For the neutral drugs the
previous fasted and fed studies had described a more complex pattern
with eight and ﬁfteen signiﬁcant interactions respectively. Surprisingly
the full range experiment is not reﬂecting this result since only two
signiﬁcant factors were present (sodium oleate with pH and bile salt).
The reduced experiment full range DoE is therefore picking up fewer
signiﬁcant factors and factor interactions than the larger focussed ex-
perimental studies.
3.6. Comparison of full range DoE with published fasted and fed DoE
For each compound the signiﬁcance of individual media factors
standardised eﬀect on the equilibrium solubility is presented in Table 3
juxtaposed to the published fasted and fed DoE results. The factor least
consistent with previous studies is lecithin (2 matches from 9 drugs)
followed by buﬀer (3 matches from 9 drugs), salt, monoglyceride and
Fig. 5. Standardised eﬀect values for DoE factor interactions on
equilibrium solubility.
Legend: DoE standardised eﬀect values (x-axis) for interactions
between factors (as listed in ﬁgure titles) on equilibrium solu-
bility in the fasted (fa), fed (fe) and full range (full) experiment.
Vertical dashed black lines indicate statistical signiﬁcance
(p < 0.05), bar direction indicates direction of eﬀect, to the
right of 0 on x axis is positive eﬀect on solubility, bar length
indicates the magnitude of the eﬀect. Full: value from current
study, Fa: fasted data from (Khadra et al., 2015), Fe: fed data
from (Zhou et al., 2017). NB For each drug non-statistically
signiﬁcant factor interactions in this study are not presented.
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bile salt are intermediate (4 or 5 matches from 9 drugs) with pH (6
matches from 9 drugs) and oleate (7 matches from 9 drugs) the most
consistent. In addition for any factor the full range study has the lowest
number of signiﬁcant ﬁndings when compared to the published studies
a result also applicable to two way factor interactions. The diﬀerence in
the ability to detect the signiﬁcance of a factor's contribution to equi-
librium solubility may be due to a number of diﬀerences between the
studies. The reduced number of sample points for the full range (32 vs
66 (fasted) or 92 (fed)) study must reduce the statistical resolution and
therefore only factors which are highly signiﬁcant or not signiﬁcant are
detected correctly, see Fig. 4 and Table 3. In addition a design of ex-
periment statistically combines high and low levels of a factor to con-
struct the measurement points, covering the full range (fasted to fed)
will produce factor ratios that are not likely to be biorelevant (Riethorst
et al., 2015). This may be why lecithin has the lowest consistency since
the inﬂuence of lecithin observed in the previous published DoEs
(Khadra et al., 2015; Zhou et al., 2017) was the least signiﬁcant it is not
reproduced or captured in this full range study. The importance of the
“solubilizing” capacity (combination of bile salt, lecithin, and sodium
oleate) has been reported to signiﬁcantly enhance solubility (Kleberg
et al., 2010; Pedersen et al., 2000b; Soderlind et al., 2010) but this is
not evident in this study. Further more detailed studies with increased
drug numbers and properties along with scaled experimental number
design of experiment approaches would be required to fully elucidate
the reasons for these ﬁndings.
4. Conclusions
The objective of this study was to determine the feasibility of
combining the previous fasted and fed DoE into one smaller full range
experiment in order to obtain comparable results regarding the inﬂu-
ence of gastrointestinal media components on the equilibrium solubility
of BCS class II drugs. This full range DoE produced interesting results
regarding the general solubility space, which overall is comparable to
published fasted (Khadra et al., 2015), fed (Zhou et al., 2017), simu-
lated and human intestinal ﬂuid equilibrium solubility values
Fig. 5. (continued)
J. Perrier et al. (XURSHDQ-RXUQDORI3KDUPDFHXWLFDO6FLHQFHV²

(Augustijns et al., 2014). A statistical comparison of the published
fasted and fed solubility distributions indicates that these are sig-
niﬁcantly diﬀerent, with the fed higher than the fasted a result which is
in agreement with literature data based on single measurements
(Augustijns et al., 2014). A statistical comparison of the full range
measured equilibrium solubility values with a combination of the
published fasted and fed indicates that this full range experiment was
statistically equivalent to the previous fasted and fed DoE for six out of
the nine drugs tested (Fig. 2). However, for three drugs statistically
signiﬁcant diﬀerences were detected indicating that for these drugs the
full range DoE will not provide equivalent equilibrium solubility in-
formation to separate larger studies. It is likely that this behaviour will
be present in other drugs which will be most probably be either basic or
neutral in character, however further research is required to fully elu-
cidate the molecular properties that produce this eﬀect. The measured
solubility distributions for each drug in the full range experiment and
the published fasted and fed experiments was non-normal a result that
may be due to the structured sampling induced by the DoE, the fact that
the distribution is non-normal either through the presence of multiple
distributions or extreme points or that the number of data points is not
suﬃcient to sample the distribution. Further studies will be required to
determine the origin of this result however it implies that a single
solubility measurement without knowledge of the solubility distribu-
tion will be of limited value.
Overall the three drug groups exhibited a similar proﬁle with re-
spect to the most signiﬁcant factors and two way factor interactions
controlling solubility when compared to the published fasted and fed
studies. For acidic compounds unsurprisingly pH and oleate were
dominant (Khadra et al., 2015; Zhou et al., 2017) with bile salt also
signiﬁcant. For the neutral and basic drugs three factors pH, bile salt
and sodium oleate were dominant along with a two way interaction of
sodium oleate with pH and for neutral drugs only bile salt with sodium
oleate. Although there was variation between the drugs the four other
factors (lecithin, monoglyceride, salt and buﬀer) were on average not
signiﬁcant at all along with around 90% of possible two way factor
interactions. The reduced incidence of signiﬁcant eﬀects with in-
dividual factors and two way factor interactions may be a consequence
of the reduced number of measurement points within the design of
experiment and or the combination of factor values covering the fasted
and fed range leading to systems that are not biorelevant. Notably, le-
cithin did not signiﬁcantly inﬂuence solubility a result that contrasts
with previous published information as it is reported to be essential in
the solubilizing capacity of simulated intestinal ﬂuids (Soderlind et al.,
2010) and was signiﬁcant in published DoE studies (Khadra et al., 2015;
Fig. 6. Average signiﬁcant absolute standardised eﬀect va-
lues for individual factors and factor interactions.
Legend: Average signiﬁcant DoE standardised eﬀect values
for individual factors and factor interactions (as listed in
ﬁgure x-axis) on equilibrium solubility grouped by drug
category. Red coloured bars for acids, blue for basics and
yellow for neutrals. NB Only statistically signiﬁcant results
presented. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version
of this article.)
Table 3
Comparison of the statistical signiﬁcance of DoE factors.
Factor
Drug Oleate Bile Salt pH Lecithin Buffer Salt Monoglyceride
Fstd Fed Full Fstd Fed Full Fstd Fed Full Fstd Fed Full Fstd Fed Full Fstd Fed Full Fstd Fed Full
Phenytoin S S S S S NS S S S S NS NS S NS NS S NS NS - S NS
Indomethacin S S S S S S S S S NS NS NS S NS NS NS NS NS - NS NS
Aprepitant S S S S S NS S S S NS S NS NS S NS NS S NS - NS NS
Tadalafil S S S S S S S NS NS S NS NS S NS NS S NS NS - NS NS
Zafirlukast S NS NS S S S S S S S NS NS NS NS NS NS NS NS - NS NS
Carvedilol S S S S S NS S S S S NS NS NS S NS NS NS NS - S NS
Felodipine S S S S S S S S S S S S NS NS NS NS NS NS - NS NS
Fenofibrate S S S S S S S NS NS S S NS S S NS S NS S - S NS
Probucol S S NS NS S NS S S NS NS S NS NS NS NS NS S NS - S NS
Total Significant 9 8 7 8 9 5 9 7 6 6 4 1 4 3 0 3 2 1 - 4 0
Fstd = fasted media design of experiment (Khadra et al., 2015 #9648).
Fed = fed media design of experiment (Zhou et al., 2017 #10289).
Full = full range media design of experiment.
- monoglyceride not included in fasted media design of experiment.
S = factor statistically signiﬁcant in design of experiment study.
NS = factor not statistically signiﬁcant in design of experiment study.
Shaded box = no consistent result between studies.
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Zhou et al., 2017).
The reduced experiment full range DoE study therefore provides
equilibrium solubility values that for the majority of drugs will be
equivalent to larger studies but with a lower statistical ability to
identify the signiﬁcant factors and factor interactions that inﬂuence
solubility. Further statistical reﬁnement might be possible to tease out
the diﬀerences between the fasted and fed states using for example a
dual small scale DoE covering both states. This might also provide in-
formation to determine why some drugs do not produce equivalent
solubility results between DoE approaches.
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